Related Experiment Video
Updated: Jul 15, 2026
10:27
Lipid-Protein Membrane Structure-Function Characterization using Droplet Interface Bilayers
Published on: June 12, 2026
Swedish experience of the Dialock.
George Metry1, Fredrik Uhlin, Gabriel Almroth
1Department of Nephrology, University Hospital of Linköping, Linköping, Sweden.
Scandinavian Journal of Urology and Nephrology
|May 1, 2007
Summary
The Dialock access device for haemodialysis showed acceptable patency, comparable to arteriovenous fistulas, despite complications like bleeding and infection in some patients.
Area of Science:
- Nephrology
- Vascular Surgery
Background:
- Vascular access is crucial for haemodialysis.
- The Dialock device was evaluated for its efficacy and safety.
Observation:
- A retrospective study of 7 patients using 10 Dialock devices (2000-2004).
- Mean patency was 16.3 months.
- Complications included bleeding (3 patients) and infection (4 patients).
Findings:
- Dialock demonstrated 1-year patency rates similar to arteriovenous fistulas.
- 3 out of 7 patients experienced no complications.
Implications:
- Dialock is a viable option for haemodialysis patients with vascular access challenges.
- Future similar devices may address needs for patients with difficult vascular access.
Related Concept Videos
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...